论文信息 - MiR 31 3p as a predictive biomarker of cetuximab efficacy effect in metastatic colorectal cancer (mCRC) patients enrolled in FIRE-3 study. - 字舞流文

MiR 31 3p as a predictive biomarker of cetuximab efficacy effect in metastatic colorectal cancer (mCRC) patients enrolled in FIRE-3 study.

P. Laurent-Puig | V. Heinemann | F. Bonnetain | A. Jung | D. Neureiter | F. Liébaert | C. Vazart | K. Fontaine | S. Stintzing | F. Rousseau | M. Grisoni | R. Thiébaut | V. Decaulne | B. Courtieu